BFRIBiofrontera Inc.Finished
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
Actinic Keratoses
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 3
- Patients
- 172 (final count)
- Started
- Dec 12, 2022
- Main results expected
- Sep 3, 2025
- Fully finished
- Jul 1, 2026
- Results posted
- Aug 21, 2026
What counts as success
The trial's main goal(s), called the “primary outcome.”
Overall Subject Complete Response Rate
Measured over: 12 weeks after the last PDT (Visit 4 or Visit 6)
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT05662202 · record last updated 2026-08-21 · checked 2026-11-09 15:47 UTC